2018 Apr 09
David Nanus, M.D., Talks to OncLive on Managing Side Effects from Immunotherapy in RCC
Video of Dr. Nanus on Managing Side Effects from Immunotherapy in RCC Read more
2018 Apr 05
Healthcare Analytics News Interviews Heather Yeo, M.D., M.H.S., on mHealth
The article "Reducing Postoperative Readmissions: There's an App for That" discusses Dr. Heather Yeo's smartphone app that prompts patients to adhere to optimal postoperative care. The full article can be found here: http://... Read more
2018 Apr 04
Koen van Besien, M.D., Ph.D., on Autologous Stem Cell Transplantation in Hematologic Malignancies
Video of Dr. van Besien on Autologous Stem Cell Transplantation in Hematologic Malignancies Read more
2018 Jan 17
MCC Director Lewis Cantley, Ph.D., and team Reveal a Key Cancer Mechanism
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and... Read more
2018 Jan 08
Selina Chen-Kiang, Ph.D., Receives Funding from the Leukemia & Lymphoma Society's New Research Program
Selina Chen-Kiang, Ph.D., is the recipient of a grant from the Leukemia & Lymphoma Society's new research program in Mantle Cell Lymphoma (MCL). She and her team investigate the efficacy of a therapy approved for breast... Read more
2018 Jan 05
Peter Martin, M.D., Talks Trial of Oral Azacitidine Plus R-CHOP in High Risk DLBCL
Video of Dr. Martin on Trial of Oral Azacitidine Plus R-CHOP in High Risk DLBCL Peter Martin, M.D., discusses a trial of the combination of oral azacitidine (CC-486) and R-CHOP in diffuse large B-cell lymphoma (DLBCL). This... Read more
2017 Dec 28
The Value of MIPI and Ki-67 in Mantle Cell Lymphoma
Video of The Value of MIPI and Ki-67 in Mantle Cell Lymphoma John P. Leonard, M.D., interim chair of the Department of Medicine, associate dean of clinical research, Richard T. Silver Distinguished Professor of Hematology... Read more
2017 Dec 11
Signs of acute myeloid leukemia may be present years before diagnosis
Patients with acute myeloid leukemia (AML) may have genetic mutations in their blood indicating they are at high risk of developing the disease about nine years before diagnosis , according to research from Weill Cornell... Read more
2017 Dec 06
Silvia C. Formenti, M.D., Gives Keynote Lecture at the 2017 San Antonio Breast Cancer Symposium
Video of Keynote Lecture: Silvia C. Formenti, MD, on Converting Tumors Into in Situ Vaccines With Radiation Therapy In her keynote lecture at the 2017 San Antonio Breast Cancer Symposium, Silvia C. Formenti, M.D., Professor... Read more
2017 Nov 30
Dan A. Landau, M.D., Ph.D., Receives the the 2017 Joanne Levy, M.D., Memorial Award for Outstanding Achievement from the American Society of Hematology
Dan A. Landau, M.D., Ph.D., assistant professor of m edicine in hematology/oncology and assistant professor in physiology and biophysics, will receive the 2017 Joanne Levy, M.D., Memorial Award for Outstanding Achievement... Read more
2017 Nov 20
Jessica Tyler, Ph.D., Elected Fellow of AAAS
Dr. Jessica Tyler , who was recruited to Weill Cornell Medicine as a professor of pathology and laboratory medicine, has been elected a fellow of the American Association for the Advancement of Science (AAAS). Dr. Tyler was... Read more
2017 Nov 20
Mark M. Souweidane, M.D., Named to NCI’s Brain Malignancies Steering Committee
Mark Souweidane, M.D., has been selected by the National Cancer Institute (NCI) to serve as a member of its Brain Malignancies Steering Committee (BMSC). The committee is charged with reviewing and prioritizing Phase 2 and... Read more
2017 Nov 17
Todd Evans, Ph.D., Talks Cancer Organoids with the Daily Beast
Would you trust a 3D-printed mini organ to test your drugs? The Daily Beast's article on the matter features the perspective of Todd Evans, Ph.D., Associate Dean for Research. Read more
2017 Oct 27
L.A. Times Op-Ed Features MCC Director Lewis Cantley, Ph.D.
Science journalist Sam Apple interviewed Dr. Lewis Cantley for his opinion piece in the Los Angeles Times on the connection between sugar and cancer. Read more
2017 Oct 18
Shining a Light
When Dr. Onyinye Balogun was a young girl, her father’s only sister was diagnosed with breast cancer back home in their native Nigeria. Dr. Balogun had recently immigrated to the United States with her parents, but on a... Read more
2017 Oct 12
Ana Gomes, Ph.D., Selected as a 2017 STAT Wunderkind
As you get older, your risk of developing cancer increases. That might seem obvious, but Ana Gomes, Ph.D., wants to know why. She’s studying a chemical, found more prominently in older people than young, and how it may be... Read more
2017 Oct 06
Neuro-Oncologist Dr. Howard Fine Wins NIH Director’s Pioneer Award
Internationally renowned neuro-oncologist Dr. Howard A. Fine of Weill Cornell Medicine and NewYork-Presbyterian will receive a five-year, $6 million National Institutes of Health Director’s Pioneer Award for brain cancer... Read more
2017 Oct 05
Neuro-Oncologist Dr. Howard Fine Wins NIH Director’s Pioneer Award
NEW YORK (October 5, 2017) — Internationally renowned neuro-oncologist Dr. Howard A. Fine of Weill Cornell Medicine and NewYork-Presbyterian will receive a five-year, $6 million National Institutes of Health Director’s... Read more
2017 Oct 05
MCC Researchers Receive Prostate Cancer Foundation 2017 Challenge Awards
Two of the 2017 Prostate Cancer Foundation (PCF) Challenge Awards were awarded to teams including Meyer Cancer Center investigators. Optimization of Prostate-Specific Membrane Antigen-Targeted Radiation ($1 million): Scott... Read more
2017 Oct 02
American Society of Hematology Bridge Grant Awarded to Selina Chen-Kiang, Ph.D.,
American Society of Hematology (ASH) announced the names of five investigators whose research has been awarded $150,000 through the ASH Bridge Grant Program. Meyer Cancer Center member Selina Chen-Kiang, Ph.D. was one of the... Read more
